147 related articles for article (PubMed ID: 8980294)
1. Iontophoretic delivery of ALA provides a quantitative model for ALA pharmacokinetics and PpIX phototoxicity in human skin.
Rhodes LE; Tsoukas MM; Anderson RR; Kollias N
J Invest Dermatol; 1997 Jan; 108(1):87-91. PubMed ID: 8980294
[TBL] [Abstract][Full Text] [Related]
2. A quantitative assessment of protoporphyrin IX metabolism and phototoxicity in human skin following dose-controlled delivery of the prodrugs 5-aminolaevulinic acid and 5-aminolaevulinic acid-n-pentylester.
Gerscher S; Connelly JP; Beijersbergen Van Henegouwen GM; MacRobert AJ; Watt P; Rhodes LE
Br J Dermatol; 2001 May; 144(5):983-90. PubMed ID: 11359385
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the pharmacokinetics and phototoxicity of protoporphyrin IX metabolized from 5-aminolevulinic acid and two derivatives in human skin in vivo.
Gerscher S; Connelly JP; Griffiths J; Brown SB; MacRobert AJ; Wong G; Rhodes LE
Photochem Photobiol; 2000 Oct; 72(4):569-74. PubMed ID: 11045731
[TBL] [Abstract][Full Text] [Related]
4. The effect of an iron chelating agent on protoporphyrin IX levels and phototoxicity in topical 5-aminolaevulinic acid photodynamic therapy.
Choudry K; Brooke RC; Farrar W; Rhodes LE
Br J Dermatol; 2003 Jul; 149(1):124-30. PubMed ID: 12890205
[TBL] [Abstract][Full Text] [Related]
5. Oral aminolevulinic acid induces protoporphyrin IX fluorescence in psoriatic plaques and peripheral blood cells.
Bissonnette R; Zeng H; McLean DI; Korbelik M; Lui H
Photochem Photobiol; 2001 Aug; 74(2):339-45. PubMed ID: 11547574
[TBL] [Abstract][Full Text] [Related]
6. Quantitative model calculation of the time-dependent protoporphyrin IX concentration in normal human epidermis after delivery of ALA by passive topical application or lontophoresis.
Star WM; Aalders MC; Sac A; Sterenborg HJ
Photochem Photobiol; 2002 Apr; 75(4):424-32. PubMed ID: 12003134
[TBL] [Abstract][Full Text] [Related]
7. Microneedle pre-treatment of human skin improves 5-aminolevulininc acid (ALA)- and 5-aminolevulinic acid methyl ester (MAL)-induced PpIX production for topical photodynamic therapy without increase in pain or erythema.
Mikolajewska P; Donnelly RF; Garland MJ; Morrow DI; Singh TR; Iani V; Moan J; Juzeniene A
Pharm Res; 2010 Oct; 27(10):2213-20. PubMed ID: 20676735
[TBL] [Abstract][Full Text] [Related]
8. Topical aminolaevulinic acid- and aminolaevulinic acid methyl ester-based photodynamic therapy with red and violet light: influence of wavelength on pain and erythema.
Mikolajewska P; Iani V; Juzeniene A; Moan J
Br J Dermatol; 2009 Nov; 161(5):1173-9. PubMed ID: 19785604
[TBL] [Abstract][Full Text] [Related]
9. Relationship of protoporphyrin IX synthesis to photodynamic effects by 5-aminolaevulinic acid and its esters on various cell lines derived from the skin.
Lee JB; Choi JY; Chun JS; Yun SJ; Lee SC; Oh J; Park HR
Br J Dermatol; 2008 Jul; 159(1):61-7. PubMed ID: 18489589
[TBL] [Abstract][Full Text] [Related]
10. A time course investigation of the fluorescence induced by topical application of 5-aminolevulinic acid and methyl aminolevulinate on normal human skin.
Lesar A; Ferguson J; Moseley H
Photodermatol Photoimmunol Photomed; 2009 Aug; 25(4):191-5. PubMed ID: 19614897
[TBL] [Abstract][Full Text] [Related]
11. Fluorescence characteristics and pharmacokinetic properties of a novel self-adhesive 5-ALA patch for photodynamic therapy of actinic keratoses.
Fauteck JD; Ackermann G; Birkel M; Breuer M; Moor AC; Ebeling A; Ortland C
Arch Dermatol Res; 2008 Feb; 300(2):53-60. PubMed ID: 17960406
[TBL] [Abstract][Full Text] [Related]
12. The effect of light fractionation with a 2-h dark interval on the efficacy of topical hexyl-aminolevulinate photodynamic therapy in normal mouse skin.
Middelburg TA; de Bruijn HS; van der Ploeg-van den Heuvel A; Neumann HA; Robinson DJ
Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):703-9. PubMed ID: 24284130
[TBL] [Abstract][Full Text] [Related]
13. Topical application of 5-aminolevulinic acid and its methylester, hexylester and octylester derivatives: considerations for dosimetry in mouse skin model.
Juzeniene A; Juzenas P; Iani V; Moan J
Photochem Photobiol; 2002 Sep; 76(3):329-34. PubMed ID: 12403455
[TBL] [Abstract][Full Text] [Related]
14. Pain associated with photodynamic therapy using 5-aminolevulinic acid or 5-aminolevulinic acid methylester on tape-stripped normal skin.
Wiegell SR; Stender IM; Na R; Wulf HC
Arch Dermatol; 2003 Sep; 139(9):1173-7. PubMed ID: 12975159
[TBL] [Abstract][Full Text] [Related]
15. Protoporphyrin IX fluorescence kinetics in UV-induced tumours and normal skin of hairless mice after topical application of 5-aminolevulinic acid methyl ester.
Juzenas P; Sharfaei S; Moan J; Bissonnette R
J Photochem Photobiol B; 2002 May; 67(1):11-7. PubMed ID: 12007462
[TBL] [Abstract][Full Text] [Related]
16. Pre-treatment protoporphyrin IX concentration in actinic keratosis lesions may be a predictive biomarker of response to aminolevulinic-acid based photodynamic therapy.
Kanick SC; Davis SC; Zhao Y; Sheehan KL; Hasan T; Maytin EV; Pogue BW; Chapman MS
Photodiagnosis Photodyn Ther; 2015 Dec; 12(4):561-6. PubMed ID: 26480810
[TBL] [Abstract][Full Text] [Related]
17. Topical 5-aminolevulinic acid-photodynamic therapy of hairless mouse skin using two-fold illumination schemes: PpIX fluorescence kinetics, photobleaching and biological effect.
Robinson DJ; de Bruijn HS; de Wolf WJ; Sterenborg HJ; Star WM
Photochem Photobiol; 2000 Dec; 72(6):794-802. PubMed ID: 11140268
[TBL] [Abstract][Full Text] [Related]
18. Kinetics and localisation of PpIX fluorescence after topical and systemic ALA application, observed in skin and skin tumours of UVB-treated mice.
van der Veen N; de Bruijn HS; Berg RJ; Star WM
Br J Cancer; 1996 Apr; 73(7):925-30. PubMed ID: 8611408
[TBL] [Abstract][Full Text] [Related]
19. Intracutaneous ALA photodynamic therapy: dose-dependent targeting of skin structures.
Sakamoto FH; Doukas AG; Farinelli WA; Tannous Z; Su Y; Smith NA; Zurakowski D; Anderson RR
Lasers Surg Med; 2011 Sep; 43(7):621-31. PubMed ID: 22057490
[TBL] [Abstract][Full Text] [Related]
20. Effect of elevating the skin temperature during topical ALA application on in vitro ALA penetration through mouse skin and in vivo PpIX production in human skin.
van den Akker JT; Boot K; Vernon DI; Brown SB; Groenendijk L; van Rhoon GC; Sterenborg HJ
Photochem Photobiol Sci; 2004 Mar; 3(3):263-7. PubMed ID: 14993942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
